HireRight Holdings Corporation

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, ADP has a market cap of 126.2B. Regarding current trading prices, HRT is priced at $14.36, while ADP trades at $310.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas ADP's P/E ratio is 31.79. In terms of profitability, HRT's ROE is -0.02%, compared to ADP's ROE of +0.77%. Regarding short-term risk, HRT is less volatile compared to ADP. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check ADP's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, PAYX has a market cap of 52.6B. Regarding current trading prices, HRT is priced at $14.36, while PAYX trades at $145.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas PAYX's P/E ratio is 31.86. In terms of profitability, HRT's ROE is -0.02%, compared to PAYX's ROE of +0.41%. Regarding short-term risk, HRT is less volatile compared to PAYX. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check PAYX's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, BZ has a market cap of 4.5B. Regarding current trading prices, HRT is priced at $14.36, while BZ trades at $19.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas BZ's P/E ratio is 33.60. In terms of profitability, HRT's ROE is -0.02%, compared to BZ's ROE of +0.12%. Regarding short-term risk, HRT is less volatile compared to BZ. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check BZ's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, RHI has a market cap of 3.8B. Regarding current trading prices, HRT is priced at $14.36, while RHI trades at $37.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas RHI's P/E ratio is 21.40. In terms of profitability, HRT's ROE is -0.02%, compared to RHI's ROE of +0.13%. Regarding short-term risk, HRT is less volatile compared to RHI. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check RHI's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, KFY has a market cap of 3.7B. Regarding current trading prices, HRT is priced at $14.36, while KFY trades at $71.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas KFY's P/E ratio is 15.58. In terms of profitability, HRT's ROE is -0.02%, compared to KFY's ROE of +0.14%. Regarding short-term risk, HRT is less volatile compared to KFY. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check KFY's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, TNET has a market cap of 3.4B. Regarding current trading prices, HRT is priced at $14.36, while TNET trades at $69.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas TNET's P/E ratio is 23.60. In terms of profitability, HRT's ROE is -0.02%, compared to TNET's ROE of +1.57%. Regarding short-term risk, HRT is less volatile compared to TNET. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check TNET's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, NSP has a market cap of 2.3B. Regarding current trading prices, HRT is priced at $14.36, while NSP trades at $60.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas NSP's P/E ratio is 35.63. In terms of profitability, HRT's ROE is -0.02%, compared to NSP's ROE of +0.52%. Regarding short-term risk, HRT is less volatile compared to NSP. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check NSP's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, MAN has a market cap of 2B. Regarding current trading prices, HRT is priced at $14.36, while MAN trades at $42.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas MAN's P/E ratio is -117.94. In terms of profitability, HRT's ROE is -0.02%, compared to MAN's ROE of -0.01%. Regarding short-term risk, HRT is less volatile compared to MAN. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check MAN's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, UPWK has a market cap of 1.6B. Regarding current trading prices, HRT is priced at $14.36, while UPWK trades at $12.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas UPWK's P/E ratio is 7.27. In terms of profitability, HRT's ROE is -0.02%, compared to UPWK's ROE of +0.48%. Regarding short-term risk, HRT is less volatile compared to UPWK. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check UPWK's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, BBSI has a market cap of 1.2B. Regarding current trading prices, HRT is priced at $14.36, while BBSI trades at $46.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas BBSI's P/E ratio is 23.87. In terms of profitability, HRT's ROE is -0.02%, compared to BBSI's ROE of +0.25%. Regarding short-term risk, HRT is less volatile compared to BBSI. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check BBSI's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, HSII has a market cap of 929.8M. Regarding current trading prices, HRT is priced at $14.36, while HSII trades at $45.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas HSII's P/E ratio is 125.25. In terms of profitability, HRT's ROE is -0.02%, compared to HSII's ROE of +0.02%. Regarding short-term risk, HRT is less volatile compared to HSII. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check HSII's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, HHR has a market cap of 761.1M. Regarding current trading prices, HRT is priced at $14.36, while HHR trades at $15.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas HHR's P/E ratio is 9.05. In terms of profitability, HRT's ROE is -0.02%, compared to HHR's ROE of +0.58%. Regarding short-term risk, HRT is less volatile compared to HHR. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check HHR's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, KFRC has a market cap of 680.2M. Regarding current trading prices, HRT is priced at $14.36, while KFRC trades at $36.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas KFRC's P/E ratio is 14.32. In terms of profitability, HRT's ROE is -0.02%, compared to KFRC's ROE of +0.30%. Regarding short-term risk, HRT is less volatile compared to KFRC. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check KFRC's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, KELYB has a market cap of 476.9M. Regarding current trading prices, HRT is priced at $14.36, while KELYB trades at $13.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas KELYB's P/E ratio is -23.32. In terms of profitability, HRT's ROE is -0.02%, compared to KELYB's ROE of -0.02%. Regarding short-term risk, HRT is less volatile compared to KELYB. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check KELYB's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, KELYA has a market cap of 439.8M. Regarding current trading prices, HRT is priced at $14.36, while KELYA trades at $12.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas KELYA's P/E ratio is -21.91. In terms of profitability, HRT's ROE is -0.02%, compared to KELYA's ROE of -0.02%. Regarding short-term risk, HRT is less volatile compared to KELYA. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check KELYA's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, ZIP has a market cap of 393.4M. Regarding current trading prices, HRT is priced at $14.36, while ZIP trades at $4.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas ZIP's P/E ratio is -22.29. In terms of profitability, HRT's ROE is -0.02%, compared to ZIP's ROE of -1.91%. Regarding short-term risk, HRT is less volatile compared to ZIP. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check ZIP's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, TBI has a market cap of 215.8M. Regarding current trading prices, HRT is priced at $14.36, while TBI trades at $7.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas TBI's P/E ratio is -1.57. In terms of profitability, HRT's ROE is -0.02%, compared to TBI's ROE of -0.43%. Regarding short-term risk, HRT is less volatile compared to TBI. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check TBI's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, HQI has a market cap of 140.1M. Regarding current trading prices, HRT is priced at $14.36, while HQI trades at $10.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas HQI's P/E ratio is 38.50. In terms of profitability, HRT's ROE is -0.02%, compared to HQI's ROE of +0.05%. Regarding short-term risk, HRT is less volatile compared to HQI. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check HQI's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, DHX has a market cap of 130.7M. Regarding current trading prices, HRT is priced at $14.36, while DHX trades at $2.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas DHX's P/E ratio is -15.76. In terms of profitability, HRT's ROE is -0.02%, compared to DHX's ROE of -0.07%. Regarding short-term risk, HRT is less volatile compared to DHX. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check DHX's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, VOLT has a market cap of 98.8M. Regarding current trading prices, HRT is priced at $14.36, while VOLT trades at $27.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas VOLT's P/E ratio is 29.67. In terms of profitability, HRT's ROE is -0.02%, compared to VOLT's ROE of +0.05%. Regarding short-term risk, HRT is less volatile compared to VOLT. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check VOLT's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, MHH has a market cap of 85.6M. Regarding current trading prices, HRT is priced at $14.36, while MHH trades at $7.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas MHH's P/E ratio is 42.79. In terms of profitability, HRT's ROE is -0.02%, compared to MHH's ROE of +0.02%. Regarding short-term risk, HRT is less volatile compared to MHH. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check MHH's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, BGSF has a market cap of 68.6M. Regarding current trading prices, HRT is priced at $14.36, while BGSF trades at $6.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas BGSF's P/E ratio is -19.83. In terms of profitability, HRT's ROE is -0.02%, compared to BGSF's ROE of -0.03%. Regarding short-term risk, HRT is less volatile compared to BGSF. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check BGSF's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, NIXX has a market cap of 36.1M. Regarding current trading prices, HRT is priced at $14.36, while NIXX trades at $1.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas NIXX's P/E ratio is -0.49. In terms of profitability, HRT's ROE is -0.02%, compared to NIXX's ROE of -6.03%. Regarding short-term risk, HRT is less volatile compared to NIXX. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check NIXX's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, NIXXW has a market cap of 33.6M. Regarding current trading prices, HRT is priced at $14.36, while NIXXW trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas NIXXW's P/E ratio is N/A. In terms of profitability, HRT's ROE is -0.02%, compared to NIXXW's ROE of -6.03%. Regarding short-term risk, HRT is more volatile compared to NIXXW. This indicates potentially higher risk in terms of short-term price fluctuations for HRT.Check NIXXW's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, HSON has a market cap of 23.8M. Regarding current trading prices, HRT is priced at $14.36, while HSON trades at $9.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas HSON's P/E ratio is -7.02. In terms of profitability, HRT's ROE is -0.02%, compared to HSON's ROE of -0.09%. Regarding short-term risk, HRT is less volatile compared to HSON. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check HSON's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, JOB has a market cap of 22.2M. Regarding current trading prices, HRT is priced at $14.36, while JOB trades at $0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas JOB's P/E ratio is -0.40. In terms of profitability, HRT's ROE is -0.02%, compared to JOB's ROE of -0.73%. Regarding short-term risk, HRT is less volatile compared to JOB. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check JOB's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, RCRT has a market cap of 11M. Regarding current trading prices, HRT is priced at $14.36, while RCRT trades at $2.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas RCRT's P/E ratio is -0.98. In terms of profitability, HRT's ROE is -0.02%, compared to RCRT's ROE of -34.88%. Regarding short-term risk, HRT is less volatile compared to RCRT. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check RCRT's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, GLXG has a market cap of 10.3M. Regarding current trading prices, HRT is priced at $14.36, while GLXG trades at $0.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas GLXG's P/E ratio is -19.15. In terms of profitability, HRT's ROE is -0.02%, compared to GLXG's ROE of -0.02%. Regarding short-term risk, HRT is less volatile compared to GLXG. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check GLXG's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, EPWK has a market cap of 9.3M. Regarding current trading prices, HRT is priced at $14.36, while EPWK trades at $0.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas EPWK's P/E ratio is -6.16. In terms of profitability, HRT's ROE is -0.02%, compared to EPWK's ROE of +0.18%. Regarding short-term risk, HRT is less volatile compared to EPWK. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check EPWK's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, CLIK has a market cap of 6.9M. Regarding current trading prices, HRT is priced at $14.36, while CLIK trades at $0.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas CLIK's P/E ratio is 6.40. In terms of profitability, HRT's ROE is -0.02%, compared to CLIK's ROE of +0.16%. Regarding short-term risk, HRT is less volatile compared to CLIK. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check CLIK's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, IPDN has a market cap of 4.6M. Regarding current trading prices, HRT is priced at $14.36, while IPDN trades at $2.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas IPDN's P/E ratio is -1.24. In terms of profitability, HRT's ROE is -0.02%, compared to IPDN's ROE of -0.66%. Regarding short-term risk, HRT is less volatile compared to IPDN. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check IPDN's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, PIXY has a market cap of 3.3M. Regarding current trading prices, HRT is priced at $14.36, while PIXY trades at $6.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas PIXY's P/E ratio is 0.01. In terms of profitability, HRT's ROE is -0.02%, compared to PIXY's ROE of +0.26%. Regarding short-term risk, HRT is less volatile compared to PIXY. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check PIXY's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, STAF has a market cap of 2.7M. Regarding current trading prices, HRT is priced at $14.36, while STAF trades at $1.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas STAF's P/E ratio is -0.04. In terms of profitability, HRT's ROE is -0.02%, compared to STAF's ROE of +2.10%. Regarding short-term risk, HRT is more volatile compared to STAF. This indicates potentially higher risk in terms of short-term price fluctuations for HRT.Check STAF's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, RCRTW has a market cap of 11.5K. Regarding current trading prices, HRT is priced at $14.36, while RCRTW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas RCRTW's P/E ratio is N/A. In terms of profitability, HRT's ROE is -0.02%, compared to RCRTW's ROE of -6.03%. Regarding short-term risk, HRT is less volatile compared to RCRTW. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check RCRTW's competition here

HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HRT stands at 967.2M. In comparison, JOBS has a market cap of 0. Regarding current trading prices, HRT is priced at $14.36, while JOBS trades at $60.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HRT currently has a P/E ratio of -130.55, whereas JOBS's P/E ratio is 42.20. In terms of profitability, HRT's ROE is -0.02%, compared to JOBS's ROE of +0.05%. Regarding short-term risk, HRT is more volatile compared to JOBS. This indicates potentially higher risk in terms of short-term price fluctuations for HRT.Check JOBS's competition here